Holen Sie sich die Stockscreener-App
0.7834
6.15%
0.0454
Schlusskurs vom Vortag:
$0.738
Offen:
$0.73995
24-Stunden-Volumen:
329.11K
Relative Volume:
2.10
Marktkapitalisierung:
$51.24M
Einnahmen:
$34.08M
Nettoeinkommen (Verlust:
$-808.00K
KGV:
-55.96
EPS:
-0.014
Netto-Cashflow:
$-3.56M
1W Leistung:
-8.91%
1M Leistung:
-19.75%
6M Leistung:
-45.60%
1J Leistung:
-77.68%
1-Tages-Spanne:
$0.712
$0.8699
1-Wochen-Bereich:
$0.6501
$0.8979
52-Wochen-Spanne:
$0.6501
$4.02
Health In Tech Inc Stock (HIT) Company Profile
Firmenname
Health In Tech Inc
Sektor
Branche
Telefon
888-373-0333
Adresse
701 S. COLORADO AVE, STUART
Compare HIT vs PANW, SAP, SHOP, CRM, UBER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIT
Health In Tech Inc
|
0.7834 | 56.25M | 34.08M | -808.00K | -3.56M | -0.014 |
PANW
Palo Alto Networks, Inc.
|
403.24 | 324.13B | 10.61B | 842.80M | 3.79B | 1.2157 |
SAP
Sap Se Adr
|
208.57 | 243.29B | 43.29B | 8.86B | 9.44B | 7.4066 |
SHOP
Shopify Inc
|
151.39 | 194.79B | 12.37B | 1.33B | 2.12B | 1.0172 |
CRM
Salesforce Inc
|
234.69 | 193.15B | 42.83B | 8.02B | 14.66B | 8.6388 |
UBER
Uber Technologies Inc
|
68.11 | 142.20B | 53.69B | 8.60B | 9.80B | 4.0128 |
Health In Tech Inc Aktie (HIT) Neueste Nachrichten
Health In Tech Launches HitRix Platform, Updates 2026 Revenue Outlook - marketscreener.com
Health In Tech Launches HitRix AI Insurance Platform - TipRanks
An AI insurance platform launches as Health In Tech (HIT) updates its revenue outlook. - Stock Titan
Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance - PR Newswire
WELL Health Technologies Corp. (WELL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada
An investor reports owning more than 5% of Health In Tech (HIT), with voting power shared. - Stock Titan
Tree Tech Inc. Expands Tree Service in Newton, MA as Fall Hemlock Treatment Window Opens - Carroll County Mirror-Democrat
Health In Tech (HIT) director sells 12K shares without preset trading plan - Stock Titan
Director at Health In Tech (HIT) files notice to sell shares - Stock Titan
Health In Tech (HIT) director lines up share sale tied to 2025–26 vesting - Stock Titan
Health In Tech (HIT) executive sells stock under preset trading plan - Stock Titan
Health in tech director Timothy Hayes sells $16,248 in stock By Investing.com - Investing.com Canada
Health in tech director Timothy Hayes sells $16,248 in stock - Investing.com
Health In Tech (NASDAQ:HIT) Director Timothy Hayes Sells 12,000 Shares of Stock - marketbeat.com
Health In Tech (NASDAQ: HIT) insider schedules 2026 stock sales under preset plan - stocktitan.net
Whetstone Capital Advisors LLC Purchases New Stake in Health In Tech, Inc. $HIT - marketbeat.com
The typical tech leader’s pay rose $810k since 2021—more than COOs, CFOs, and CIOs combined - finance.yahoo.com
Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026 - Stock Titan
MU: Micron Technology Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Yorkville could own 58.9% of Health In Tech (HIT) non‑affiliate shares - Stock Titan
Zacks Research Predicts Health In Tech Q3 Earnings - MarketBeat
HIT Q2 2026 Earnings: EPS Miss of 27.12% Overshadowed by Modest Share GainAnalyst Coverage Count - careplusvn.com
HIT: Contracted & Pipeline Revenue Leading Indicators That Arguably Point to Strong Prospects - Yahoo Finance
Health In Tech Earnings Call Balances Growth And Risk - tipranks.com
Health In Tech (HIT) Q2 2026 Earnings: Operating Performance Under Pressure - AlphaStreet
Health In Tech (HIT) Q2 2026 Earnings Call Transcript - AOL.com
Maxim Group Forecasts Health In Tech Q3 Earnings - MarketBeat
HIT Q2 2026 Earnings: EPS Misses Estimates by 69.5% as Losses DeepenReturn On Equity - careplusvn.com
Health In Tech, Inc. Class A Common Stock (NASDAQ: HIT) Share Price, HIT Stock News, HIT Share Price & Updates - kalkine.ca
Craig-Hallum Reaffirms Their Buy Rating on Health In Tech, Inc. Class A (HIT) - The Globe and Mail
Maxim Group Sticks to Their Buy Rating for Health In Tech, Inc. Class A (HIT) - The Globe and Mail
HIT Maintains Buy Rating -- Price Target Lowered to $3.00 by Max - GuruFocus
Health In Tech, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Health In Tech Q2 Revenue Falls 13.5% on Carrier Onboarding Timing Shift - Minichart
Health In Tech Inc (HIT) (Q2 2026) Earnings Call Highlights: Strategic Carrier Shift and Hitrix ... By GuruFocus - Investing.com Canada
Health In Tech (HIT) Q2 Revenue Declines Amid Strategic Shift; M - GuruFocus
Health In Tech, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HIT) 2026-08-13 - Seeking Alpha
Health In Tech Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Health In Tech misses Q2 2026 profit view as shares fall - Investing.com
Health In Tech Q2 2026 Earnings Call: Complete Transcript - Benzinga
Health In Tech Highlights Q2 Results and AI Platform Growth - TipRanks
Health In Tech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Health In Tech Q2 2026 Earnings Call Transcript - MarketBeat
Health In Tech holds earnings call for second quarter results - Investing.com
Form 8K Health In Tech Inc For: 13 August By Investing.com - Investing.com Canada
Health In Tech Reaffirms 2026 Outlook Amid Q2 Loss - TipRanks
Health In Tech (HIT) Q2 2026 revenue dips as it reaffirms $45–$50M outlook - Stock Titan
Health In Tech Latest Results: FY26 sales guidance affirmed at $45M-$50M - scanx.trade
Health In Tech Q2 Results: EPS Misses Estimate, Sales Beat - scanx.trade
HIT: 2026 revenue guidance reaffirmed at $45M–$50M despite recent margin and revenue declines - TradingView
Health In Tech (HIT) reaffirms 2026 $45–$50M revenue outlook amid margin pressure - Stock Titan
Finanzdaten der Health In Tech Inc-Aktie (HIT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):